Resumen

QUINTERO BUSUTIL, Mayrelis et al. Phacoemulsification in the treament of iridocorneal endothelial syndrome. Rev Cubana Oftalmol [online]. 2013, vol.26, n.3, pp. 536-541. ISSN 0864-2176.

Chloroquine-induced toxic maculopathy and visual rehabilitation through the use of microperimeter MP1. Chrloroquine is a drug that may cause visual dysfunctions, low vision and even blindness depending on dose. An accumulative dose lower than 100 g of chloroquine or a length of treatment less than one year is rarely associated to retinal injure. The toxicity risk increases when the accumulative dose exceeds 300 g (250mg/day for 3 years). This drug is used in treating autoimmune diseases. Here is the case of a 44 years-old patient, with history of rheumatoid arthritis for 14 years. Chloroquine treatment was indicated (one 250 mg tablet daily) at the time of initial diagnosis. Five years ago, he was diagnosed with chloroquine-induced maculopathy when he went to the doctor's because of low vision and asked for possible visual rehabilitation. An ophthalmologic exam, some supplementary studies and rehabilitation through the microperimeter MP1 were all performed. It was concluded that chloroquine-maculopathy with microperimetry provides improvement of several visual parameters and better visual quality for the patient.

Palabras clave : microperimeter MP1; chloroquine-induced maculopathy.

        · resumen en Español     · texto en Español     · Español ( pdf )